SCHEMBL9703973

SCHEMBL9703973

CCOC(=O)C1Nc2c(ccc(Cl)c2Cl)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
CYP1A2 P05177 3/20 0.39
CYP2C19 P33261 3/20 0.39
CYP2D6 P10635 2/20 0.39
TP53 P04637 2/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
TSHR P16473 3/20 0.36
POLB P06746 1/20 0.36
CYP2C9 P11712 3/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP3A4 P08684 2/20 0.36
HIF1A Q16665 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9703786 0.90 MEN1 (0.39) KDM4EMEN1KMT2ACYP1A2CYP2C19
SCHEMBL9704171 0.80 MAPK1 (0.40) KDM4EMAPK1
SCHEMBL11260228 0.79 KDM4E (0.42) KDM4EMEN1KMT2ACYP1A2CYP2C19
SCHEMBL9704850 0.78 MAPK1 (0.44) KDM4EMEN1KMT2ACYP1A2CYP2C19
SCHEMBL9704329 0.78 MAPK1 (0.44) KDM4EMEN1KMT2ACYP1A2CYP2C19
SCHEMBL9705021 0.73 KDM4E (0.42) KDM4EMEN1KMT2ACYP1A2CYP2C19
SCHEMBL2776008 0.73 KDM4E (0.42) KDM4EMEN1KMT2ACYP1A2CYP2C19
SCHEMBL10758398 0.71 ALDH1A1 (0.47) KDM4EMEN1KMT2ACYP1A2CYP2C19
SCHEMBL9705704 0.70 KDM4E (0.42) KDM4EMEN1KMT2ACYP1A2CYP2C19
SCHEMBL9704892 0.70 MAPT (0.46) KDM4EMEN1KMT2ACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992011245-A1 2-ACYLAMIDO DERIVATIVES OF 3,4-DIHYDRO-3-OXO-QUINOXALINE HAVING PHARMACEUTICAL ACTIVITY WARNER-LAMBERT COMPANY (US) 1992-07-09 WO disclosed